To further dissect the role of circPVT1 in altered glutaminolysis of breast cancer cells we focused on c-MYC, a well-known target of miR-33a-5p known to activate at the transcriptional activity several key metabolic enzymes. This evidence concerns the gene MYC and breast cancer.